Shantell Laketa Heiber

Array ( [id] => 7181377 [patent_doc_number] => 20040202679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Papilloma virus-like particles, fusion proteins as well as processes for their production' [patent_app_type] => new [patent_app_number] => 10/610928 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4407 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202679.pdf [firstpage_image] =>[orig_patent_app_number] => 10610928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7426470 [patent_doc_number] => 20040229809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Immunogenic peptides from the HPV E7 protein' [patent_app_type] => new [patent_app_number] => 10/603062 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6411 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229809.pdf [firstpage_image] =>[orig_patent_app_number] => 10603062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7440341 [patent_doc_number] => 20040009190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)' [patent_app_type] => new [patent_app_number] => 10/600058 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 5052 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009190.pdf [firstpage_image] =>[orig_patent_app_number] => 10600058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7429832 [patent_doc_number] => 20040001852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses' [patent_app_type] => new [patent_app_number] => 10/465645 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11335 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001852.pdf [firstpage_image] =>[orig_patent_app_number] => 10465645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982055 [patent_doc_number] => 06926899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test' [patent_app_type] => utility [patent_app_number] => 10/460503 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4093 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/926/06926899.pdf [firstpage_image] =>[orig_patent_app_number] => 10460503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347505 [patent_doc_number] => 20040248082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'RSV proteins, antibodies, compositions, methods and uses' [patent_app_type] => new [patent_app_number] => 10/456092 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 34033 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248082.pdf [firstpage_image] =>[orig_patent_app_number] => 10456092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 662206 [patent_doc_number] => 07101559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'Immunomodulatory protein and useful embodiments thereof' [patent_app_type] => utility [patent_app_number] => 10/455000 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 6706 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101559.pdf [firstpage_image] =>[orig_patent_app_number] => 10455000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361973 [patent_doc_number] => 20040091502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Circovirus sequences associated with piglet weight loss disease (PWD)' [patent_app_type] => new [patent_app_number] => 10/442180 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 24274 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091502.pdf [firstpage_image] =>[orig_patent_app_number] => 10442180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 421643 [patent_doc_number] => 07273616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-25 [patent_title] => 'Genetically engineered cell lines and systems for propagating Varicella zoster virus and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/436706 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 2889 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273616.pdf [firstpage_image] =>[orig_patent_app_number] => 10436706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395940 [patent_doc_number] => 20040022809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Cold-adapted equine influenza viruses' [patent_app_type] => new [patent_app_number] => 10/434811 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24827 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022809.pdf [firstpage_image] =>[orig_patent_app_number] => 10434811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074693 [patent_doc_number] => 20050147961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Human papillomavirus multiplexed assay' [patent_app_type] => utility [patent_app_number] => 10/513088 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9659 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147961.pdf [firstpage_image] =>[orig_patent_app_number] => 10513088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865089 [patent_doc_number] => 20060099219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process' [patent_app_type] => utility [patent_app_number] => 10/512190 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6644 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099219.pdf [firstpage_image] =>[orig_patent_app_number] => 10512190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164839 [patent_doc_number] => 20040076635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Circovirus sequences associated with piglet weight loss disease (PWD)' [patent_app_type] => new [patent_app_number] => 10/409613 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 24378 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076635.pdf [firstpage_image] =>[orig_patent_app_number] => 10409613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825774 [patent_doc_number] => 20030236396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Secretory signal sequences and uses thereof' [patent_app_type] => new [patent_app_number] => 10/410842 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15220 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236396.pdf [firstpage_image] =>[orig_patent_app_number] => 10410842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850629 [patent_doc_number] => 20060233820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus' [patent_app_type] => utility [patent_app_number] => 10/512045 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16748 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233820.pdf [firstpage_image] =>[orig_patent_app_number] => 10512045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303242 [patent_doc_number] => 20040115219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Pharmaceutical composition for prophylaxis and therapy of papillomavirus-derived diseases comprising papillomavirus antigen protein and CpG-oligodeoxynucleotide' [patent_app_type] => new [patent_app_number] => 10/408078 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8810 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115219.pdf [firstpage_image] =>[orig_patent_app_number] => 10408078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 506986 [patent_doc_number] => 07198792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Genetic immunization against cervical carcinoma' [patent_app_type] => utility [patent_app_number] => 10/406818 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 17700 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/198/07198792.pdf [firstpage_image] =>[orig_patent_app_number] => 10406818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1034391 [patent_doc_number] => 06875600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-05 [patent_title] => 'Mixed cell diagnostic systems' [patent_app_type] => utility [patent_app_number] => 10/407789 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16625 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875600.pdf [firstpage_image] =>[orig_patent_app_number] => 10407789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1195829 [patent_doc_number] => 06726910 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-27 [patent_title] => 'Immuno-reactive peptide CTL epitopes of human cytomegalovirus' [patent_app_type] => B2 [patent_app_number] => 10/405231 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15895 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/726/06726910.pdf [firstpage_image] =>[orig_patent_app_number] => 10405231 [rel_patent_id] =>[rel_patent_doc_number] =>)